SPYRE THERAPEUTICS INC (SYRE)
5 tracked managers currently hold SYRE on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | Q3 2026 | NEW | $31.8M | 0.1 % | — | 356,923 | NEW |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | ADD | $21.5M | 0.0 % | 0.0 % | 241,548 | +44,836 |
| D. E. Shaw & Co., Inc. | Q3 2026 | TRIM | $2.3M | 0.0 % | 0.0 % | 25,479 | -973 |
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | ADD | $2.2M | 0.0 % | 0.0 % | 25,100 | +12,329 |
| CITADEL ADVISORS LLC | Q3 2026 | TRIM | $1.8M | 0.0 % | 0.0 % | 20,097 | -83,003 |